- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Cancer (Diagnosis) in South Africa
Total 3297 results
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingCervical Cancer | CIN2 | CIN3South Africa
-
Jeffrey KotzenNational Research Foundation of South Africa; NTP Radioisotopes SOC LtdUnknown
-
Janssen Research & Development, LLCCompletedProstate CancerUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Netherlands, Greece, Sweden
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Belgium, Netherlands, Canada, Russian Federation, Finland, Former Serbia and Montenegro, France, Germany, Romania, United Kingdom
-
Candel Therapeutics, Inc.Active, not recruitingProstate CancerUnited States, Puerto Rico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
NovaceaAventis PharmaceuticalsUnknownProstate CancerCanada, United States
-
UNC Lineberger Comprehensive Cancer CenterFogarty International Center of the National Institute of HealthCompletedCervical CancerSouth Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis Pharmaceuticals; Eastern Cooperative... and other collaboratorsCompletedProstate Cancer | Metastatic CancerUnited States, Canada
-
DendreonCompletedProstate CancerUnited States, Canada
-
Bristol-Myers SquibbActive, not recruitingProstate CancerPoland, United States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Spain
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
SanofiCompletedProstate CancerAustralia, Portugal, Spain, Peru, Sweden, Romania, Russian Federation, Belarus, Israel, France, Italy, Denmark, Turkey, Germany, United States, Brazil, Canada, China, Czechia, Finland, Japan, Mexico, Poland, Taiwan, Ukraine
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
AmgenRecruitingProstate CancerJapan, United States, Korea, Republic of, Taiwan, Australia, Spain, Germany, Switzerland, Portugal, China
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
University of PretoriaUniversity of StellenboschRecruitingCervical Cancer | CIN2 | High Grade SilSouth Africa
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, France, United States, Australia, Brazil, Germany, Taiwan, Denmark, China, Netherlands, Japan, Canada, Finland, Italy, Hungary, Portugal, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Eli Lilly and CompanyCompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsActive, not recruitingProstate CancerUnited States, Canada
-
Myriad Genetic Laboratories, Inc.TerminatedProstate CancerUnited States
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Netherlands, United Kingdom, Belgium, Germany, Hungary, Czech Republic, Finland, Mexico, Poland, Romania, Russian Federation, Ukraine
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
University of Cape TownUnknownBiliary Stricture | Cancer of the Pancreas | Bile Duct Obstruction, Extrahepatic | Cancer of the Bile DuctSouth Africa
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
NGM Biopharmaceuticals, IncActive, not recruitingMelanoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostate Cancer | Head Neck Squamous Cell CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
AgennixTerminatedProstate CancerUnited States
-
Active Biotech ABCompletedProstate CancerFrance, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Cell GenesysTerminatedProstate CancerUnited States, France, Belgium, Canada, United Kingdom, Sweden, Netherlands, Germany
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Sunnybrook Health Sciences CentreExact ImagingRecruitingProstate CancerUnited States, Canada, Austria, France, Germany, Spain, Belgium
-
Aragon Pharmaceuticals, Inc.Active, not recruiting
-
Columbia UniversityBill and Melinda Gates Foundation; University of Cape Town; EngenderHealthTerminated
-
Achieve Life SciencesTeva Branded Pharmaceutical Products R&D, Inc.CompletedProstate CancerUnited States, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia